Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9GR0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,627
Award facts
- Contract value 100% obligated
- $25,626.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,626.76 to AmerisourceBergen Drug Corp for KESIMPTA 20 MG/0.4 ML pens on December 18, 2025, with an ultimate completion date of December 19, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. KESIMPTA is a specialty pharmaceutical used in the treatment of multiple sclerosis, reflecting the company's role as a critical supplier of specialized medications to support military and federal healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a key vendor for federal medical procurement through competitive awards across its extensive product portfolio. The company's DLA Troop Support Medical contract serves as a comprehensive global pharmaceutical support vehicle enabling supply of brand-name and generic drugs, specialty medications, and medical supplies to military healthcare programs worldwide, including support to the Defense Health Agency and U.S. Coast Guard. This delivery order exemplifies the operational execution of that strategic contract vehicle, fulfilling specific pharmaceutical needs within the federal healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26F9GR0?
SPE2DR26F9GR0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F9GR0 worth?
The government has obligated $25,627 on SPE2DR26F9GR0.
Is contract SPE2DR26F9GR0 an order under another contract?
Yes. SPE2DR26F9GR0 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9GR0 competed?
The extent of competition for SPE2DR26F9GR0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award